| EQT |
Report |
Q2 sales volume (Bcfe) |
BEAT |
pred ~603 Bcfe vs. cons 595 Bcfe |
MEDIUM |
| EQT |
Report |
Q2 adjusted EPS |
BEAT |
pred ~$0.44 vs. cons $0.41 |
LOW |
| EQT |
Report |
Q2 free cash flow attributable to EQT |
MISS |
pred ~$190M vs. cons $200M |
LOW |
| EQT |
Guide |
Total sales volume |
LOWER |
guide ~2,325 Bcfe vs. cons 2,340 Bcfe (FY2026) |
MEDIUM |
| EQT |
Guide |
Total maintenance plus growth capital |
LOWER |
guide ~$2.70B vs. cons $2.75B (FY2026) |
MEDIUM |
| EQT |
Guide |
Sales volume |
LOWER |
guide ~545 Bcfe vs. cons 555 Bcfe (Q3 2026) |
LOW |
| EQT |
Guide |
Year-end net debt |
BETTER |
guide ~$5.0B vs. cons $5.2B (year-end 2026) |
MEDIUM |
| EQT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
MEDIUM |
| EQT |
Return |
5-day cumulative residual |
+0.6% (FADE) |
The Q2 volume beat of ~603 Bcfe vs. 595 Bcfe is likely offset by FY2026 volume guidance of ~2,325 Bcfe vs. 2,340 Bcfe consensus, implying only ~1,104 Bcfe in 2H 2026 and limiting positive estimate revisions despite lower capital spending. |
MEDIUM |